---
document_datetime: 2023-09-21 19:16:30
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/leukoscan-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: leukoscan-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.7305806
conversion_datetime: 2025-12-29 22:45:20.539909
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                                                                   | Opinion/ Notification 1 issued on Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|----------------------------------|-----------|
| IAIN/0024/G          | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up product | 18/01/2017                                                                       | SmPC, Annex II, Labelling and PL |           |

<!-- image -->

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact LeukoScan Procedural steps taken and scientific information after the authorisation 1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures. 2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). Medicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

|                    | procedure C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) in the safety database and/or major contractual arrangements for the fulfilment of PhV obligations, and/or change of the site undergoing PhV activities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | authorised                |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------|
| PSUSA/2803/ 201508 | Periodic Safety Update EU Single assessment - sulesomab                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 14/04/2016 n/a n/a longer |
| II/0022/G          | This was an application for a group of variations. Changes to the active substance and drug product manufacturing process. This was an application for a group of variations. B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological substance which may have a significant impact on the medicinal product and is not related to a protocol B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting product | 21/11/2013 no             |

<div style=\"page-break-after: always\"></div>

|         | specification limits B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.b.4.c - Change in the batch size (including batch size ranges) of the finished product - The change requires assessment of the comparability of a biological/immunological medicinal product or a new bioequivalence study B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)   |                    | no         | longer                           | authorised                                                                                                                                                                                           |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0021 | Quality changes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 21/02/2008         | 26/02/2008 |                                  |                                                                                                                                                                                                      |
| R/0020  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 14/12/2006 product | 30/05/2007 | SmPC, Annex II, Labelling and PL | Based on this second 5-year renewal dossier and the unchanged benefit-risk ratio, the licence of the Marketing Authorisation for LeukoScan has been renewed and has been granted unlimited validity. |
| II/0018 | Quality changes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 26/01/2006         | 30/01/2006 |                                  |                                                                                                                                                                                                      |
| II/0019 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 13/10/2005         | 19/10/2005 |                                  |                                                                                                                                                                                                      |
| I/0017  | Change in site for batch control/testing. 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 28/08/2003         | 17/09/2003 |                                  |                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

| R/0013   | Renewal of the marketing authorisation.                                                        | 21/02/2002   | 30/09/2002    | SmPC, Annex II, Labelling and PL PL authorised   |
|----------|------------------------------------------------------------------------------------------------|--------------|---------------|--------------------------------------------------|
| T/0016   | Transfer of Marketing Authorisation                                                            | 23/08/2002   | 18/09/2002    | SmPC, Labelling and                              |
| I/0015   | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process | 08/05/2002   | 17/06/2002    | Annex II and PL                                  |
| I/0012   | 26_Changes to comply with supplements to pharmacopoeias                                        | 15/02/2001   | 20/03/2001    | longer                                           |
| I/0011   | 01_Change following modification(s) of the manufacturing authorisation(s)                      | 06/09/2000   | 06/09/2000    |                                                  |
| I/0009   | 01_Change following modification(s) of the manufacturing authorisation(s)                      | 06/08/1999   | 17/08/1999 no |                                                  |
| I/0008   | 01_Change in the name of a manufacturer of the medicinal product                               | 26/04/1999   | 18/06/1999    | Annex II and PL                                  |
| I/0007   | 20_Extension of shelf-life as foreseen at time of authorisation product                        | 26/04/1999   | 18/06/1999    | SmPC and PL                                      |
| I/0006   | 20_Extension of shelf-life as foreseen at time of authorisation                                | 29/09/1998   | 29/03/1999    | SmPC and PL                                      |
| I/0005   | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process | 15/01/1998   | 29/03/1999    | Annex II                                         |
| I/0003   | 01_Change following modification(s) of the manufacturing authorisation(s)                      | 15/01/1998   | 29/03/1999    | SmPC, Labelling and                              |

<div style=\"page-break-after: always\"></div>

|         |                                                                 |            |            | PL          |
|---------|-----------------------------------------------------------------|------------|------------|-------------|
| II/0004 | Change(s) to the manufacturing process for the finished product | 27/05/1998 | n/a        |             |
| I/0002  | 20_Extension of shelf-life as foreseen at time of authorisation | 14/07/1997 | 08/10/1997 | SmPC and PL |

<!-- image -->